2007
DOI: 10.1038/sj.onc.1210212
|View full text |Cite
|
Sign up to set email alerts
|

Modulation of p53 and MDM2 activity by novel interaction with Ras-GAP binding proteins (G3BP)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
63
0
2

Year Published

2007
2007
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 77 publications
(68 citation statements)
references
References 19 publications
(24 reference statements)
3
63
0
2
Order By: Relevance
“…Overexpression of G3BP1 was reported to increase S-phase entry in fibroblasts, and the overexpression was associated with the intact RNAbinding domain (10). Additionally, after binding with p53, G3BP1 expression led to the redistribution of p53 from the nucleus to the cytoplasm (11). The overall evidence suggests that specifically overexpressed G3BP1 in a range of cancers might be a candidate target for anticancer agents.…”
Section: Introductionmentioning
confidence: 82%
“…Overexpression of G3BP1 was reported to increase S-phase entry in fibroblasts, and the overexpression was associated with the intact RNAbinding domain (10). Additionally, after binding with p53, G3BP1 expression led to the redistribution of p53 from the nucleus to the cytoplasm (11). The overall evidence suggests that specifically overexpressed G3BP1 in a range of cancers might be a candidate target for anticancer agents.…”
Section: Introductionmentioning
confidence: 82%
“…G3BP interacts with RAS GTPase-activating protein p120, a protein involved in the mammalian RAS signaling pathway. G3BP is essential for mouse development, and its expression is increased in many human cancer cell types (Barnes et al 2002;Kim et al 2007). Interestingly, G3BP is reported to have multiple activities related to cellular RNA metabolism, including RNA helicase activity, phosphorylation-dependent endoribonuclease activity, and cytoplasmic stress granule facilitator activity (Atlas et al 2007;Solomon et al 2007;Ortega et al 2010).…”
Section: Resultsmentioning
confidence: 99%
“…Indeed, although MDM2 interacts with proteins, fulfilling a variety of cellular functions (p300, pRb, Numb, MTBP (MDM2-binding protein), DNA polymerase ⑀, promyelocytic leukemia protein, Tip60, YY1, insulin-like growth factor 1 receptor, glucocorticoid receptor/estrogen receptor, androgen receptor, hypoxia-inducible factor 1, p73, NF-B, PSD-95, ADP ribosylation factor, E2F1, TATA-binding protein, TAFII250, Sp1, ribosomal L5, TSG 101, Ras-GAP binding proteins), the biological significance of these multiple interactions remains to be explained (for review, see Refs. 15,22). It should be stressed that not all MDM2 client proteins are targeted for proteasome-dependent degradation; hence, not all involvement of MDM2 protein can be explained by its E3 ubiquitin ligase activity (13,15).…”
mentioning
confidence: 99%